Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,990 public trials 1,836 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Phase I and Pharmacology Study of Camptothecin-20-O-Propionate Hydrate (CZ48) in Patients With Solid Tumors or Lymphoma

NCT00947739

Conditions: Advanced Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: University of New Mexico Cancer Center Albuquerque, New Mexico, United States

University of Texas Health Sciences Center San Antonio, Texas, United States

View Trial Details

Completed

Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia

NCT00563290

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +21 more
Locations: Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

Ohio State University Medical Center Columbus, Ohio, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701)

NCT00034684

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +22 more
Locations: Not specified

View Trial Details

Completed

Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures Study

NCT01032889

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Investigational Site Birmingham, Alabama, United States

Investigational Site Beverly Hills, California, United States

Investigational Site Beverly Hills, California, United States

Investigational Site San Francisco, California, United States

View Trial Details

Completed

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

NCT01542034

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Investigational Site Birmingham, Alabama, United States

Investigational Site Beverly Hills, California, United States

Investigational Site Beverly Hills, California, United States

Investigational Site Irvine, California, United States

View all 36 locations

View Trial Details

Completed

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

NCT01546142

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Investigational Site Little Rock, Arkansas, United States

Investigational Site Beverly Hills, California, United States

Investigational Site Los Angeles, California, United States

Investigational Site Sacramento, California, United States

View all 35 locations

View Trial Details

Completed

Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat

NCT01294644

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Investigational Site Geel, Belgium

Investigational Site Genk, Belgium

Investigational Site Besançon, France

Investigational Site Nice, France

View all 29 locations

View Trial Details

Completed

Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant

NCT00716911

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +66 more
Locations: Not specified

View Trial Details

Completed

A Standardized Nursing Intervention Protocol for HCT Patients

NCT00951626

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +66 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

View Trial Details

Completed

A Study of LY2875358 in Japanese Participants With Advanced Cancer

NCT01602289

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions